Filing Digest
Sep 14
Johnson & Johnson (JNJ) has announced that its RYBREVANT combination therapy has demonstrated an overall survival of 34.3 months in patients with EGFR exon 20 insertion-positive no…
Filing Digest
Sep 14
Sphere 3D Corp. filed a Current Report on Form 8-K dated September 14, 2026, to furnish an investor presentation regarding its business and operative initiatives. The filing indica…
Filing Digest
Sep 14
Nomadar Corp. has entered into a definitive Equity Purchase Agreement (EPA) to acquire a majority interest in Fox Soccer Academy (FSA). The transaction, signed on September 13, 202…
Filing Digest
Sep 14
Enbridge Inc. announced on September 14, 2026, the completion of a public offering of common shares. The company entered into an underwriting agreement on September 10, 2026, with …
Filing Digest
Sep 14
Graco Inc. (NYSE: GGG) announced the appointment of Richard B. Lewis to its Board of Directors, effective December 3, 2026. Mr. Lewis is currently the President and Chief Executive…
Filing Digest
Sep 14
Bionano Genomics, Inc. filed a Form 8-K on September 14, 2026, announcing that Albert Luderer, Ph.D., currently serving as Chairman and Interim Chief Executive Officer, is schedule…
Filing Digest
Sep 14
PennyMac Financial Services, Inc. filed a Current Report on Form 8-K on September 14, 2026, to disclose an investor update regarding the company’s business performance through the …
Filing Digest
Sep 14
Eos Energy Enterprises, Inc. has announced the receipt of an $87,018,601 advance under the second tranche of its loan agreement with the U.S. Department of Energy’s Office of Energ…
Filing Digest
Sep 14
DeFi Development Corp. (Nasdaq: DFDV) reported an increase in its Solana (SOL) treasury holdings on September 14, 2026. During the period from August 27, 2026, through September 11…
Filing Digest
Sep 14
Summit Therapeutics Inc. announced on September 13, 2026, that its partner, Akeso Inc., will present updated overall survival data from the Phase III HARMONi-2 clinical trial at th…
Filing Digest
Sep 14
Bitmine Immersion Technologies, Inc. (NYSE: BMNR) announced on September 14, 2026, that its total crypto, cash, marketable securities, and "moonshot" investments amount to $15.8 bi…
Filing Digest
Sep 14
Future Vision II Acquisition Corp. filed a Current Report on Form 8-K dated September 10, 2026, disclosing a financial obligation related to extending the company's deadline to com…
Filing Digest
Sep 14
Hyperliquid Strategies Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 14, 2026, announcing an amendment to a definitive agreement …
Filing Digest
Sep 14
Phio Pharmaceuticals Corp. (Nasdaq: PHIO) announced on September 14, 2026, that it has submitted a comprehensive briefing package to the U.S. Food and Drug Administration (FDA) to …
Filing Digest
Sep 14
Immersion Corporation reported financial results for the first quarter of fiscal 2027, which ended July 31, 2026. The company reported total revenues of $294.4 million for the thre…
Filing Digest
Sep 14
President Donald Trump signaled a potential shift in trade policy regarding Chinese automakers during an interview with Fox News on Saturday. While initially dismissing reports of …
Filing Digest
Sep 14
Immunocore Holdings plc (Nasdaq: IMCR) announced on September 14, 2026, that its registrational Phase 3 clinical trial, TEBE-AM, has achieved its target enrollment of 540 patients.…
Filing Digest
Sep 14
FrontView REIT, Inc. filed an 8-K on September 14, 2026, disclosing its acquisition and disposition activity for the first three quarters of 2026. The filing includes an Investor U…
Filing Digest
Sep 14
On September 14, 2026, Q32 Bio Inc. announced the appointment of José Trevejo, M.D., Ph.D., as Chief Medical Officer, and Ellie Hershberger, Pharm.D., as Chief Development Officer.…
Filing Digest
Sep 14
On September 14, 2026, Solid Power, Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission. The filing discloses that the company published updated pre…